Alexion Pharmaceuticals Net Income 2006-2020 | ALXN

Alexion Pharmaceuticals annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Alexion Pharmaceuticals net income for the quarter ending June 30, 2020 was $-1.068B, a 332.3% decline year-over-year.
  • Alexion Pharmaceuticals net income for the twelve months ending June 30, 2020 was $0.846B, a 36.56% decline year-over-year.
  • Alexion Pharmaceuticals annual net income for 2019 was $2.404B, a 2998.32% increase from 2018.
  • Alexion Pharmaceuticals annual net income for 2018 was $0.078B, a 82.49% decline from 2017.
  • Alexion Pharmaceuticals annual net income for 2017 was $0.443B, a 10.99% increase from 2016.
Alexion Pharmaceuticals Annual Net Income
(Millions of US $)
2019 $2,404
2018 $78
2017 $443
2016 $399
2015 $144
2014 $657
2013 $253
2012 $255
2011 $175
2010 $97
2009 $295
2008 $33
2007 $-92
2006 $-132
2005 $-109
Alexion Pharmaceuticals Quarterly Net Income
(Millions of US $)
2020-06-30 $-1,068
2020-03-31 $558
2019-12-31 $889
2019-09-30 $468
2019-06-30 $460
2019-03-31 $588
2018-12-31 $-45
2018-09-30 $331
2018-06-30 $-457
2018-03-31 $249
2017-12-31 $30
2017-09-30 $78
2017-06-30 $165
2017-03-31 $170
2016-12-31 $93
2016-09-30 $94
2016-06-30 $120
2016-03-31 $92
2015-12-31 $67
2015-09-30 $-184
2015-06-30 $170
2015-03-31 $91
2014-12-31 $153
2014-09-30 $178
2014-06-30 $166
2014-03-31 $159
2013-12-31 $-19
2013-09-30 $94
2013-06-30 $96
2013-03-31 $82
2012-12-31 $81
2012-09-30 $92
2012-06-30 $36
2012-03-31 $45
2011-12-31 $48
2011-09-30 $66
2011-06-30 $35
2011-03-31 $27
2010-12-31 $26
2010-09-30 $28
2010-06-30 $22
2010-03-31 $21
2009-12-31 $237
2009-09-30 $27
2009-06-30 $17
2009-03-31 $15
2008-12-31 $15
2008-09-30 $20
2008-06-30 $2
2008-03-31 $-4
2007-12-31 $-12
2007-09-30 $-20
2007-06-30 $-27
2007-03-31 $-33
2006-12-31 $-39
2006-09-30 $-32
2006-06-30 $-33
2006-03-31 $-27
2005-12-31
2005-10-31 $-35
2005-09-30 $-37
2005-07-31 $-33
2005-06-30 $-35
2005-04-30 $-32
2005-03-31 $-27
2005-01-31 $-24
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $22.520B $4.991B
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.427B 15.36
Bristol Myers Squibb (BMY) United States $135.060B 11.28
CSL (CSLLY) Australia $90.565B 0.00
Gilead Sciences (GILD) United States $86.552B 12.45
Vertex Pharmaceuticals (VRTX) United States $71.167B 39.71
Regeneron Pharmaceuticals (REGN) United States $68.708B 25.41
Illumina (ILMN) United States $58.909B 60.53
Biogen (BIIB) United States $43.721B 7.48
Seattle Genetics (SGEN) United States $28.290B 0.00
Moderna (MRNA) United States $28.139B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.830B 0.00
Genmab (GMAB) Denmark $23.636B 19.45
Genmab (GNMSF) Denmark $22.474B 66.72
BioMarin Pharmaceutical (BMRN) United States $21.670B 157.67
Incyte (INCY) United States $21.349B 0.00
BeiGene (BGNE) Cayman Islands $20.285B 0.00
BioNTech SE (BNTX) Germany $18.395B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.354B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.565B 70.47
Horizon Therapeutics Public (HZNP) Ireland $14.572B 36.90
Exact Sciences (EXAS) United States $13.806B 0.00
Galapagos (GLPG) Belgium $12.518B 36.82
Sarepta Therapeutics (SRPT) United States $12.392B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.879B 0.00
QIAGEN (QGEN) Netherlands $10.725B 27.22
Immunomedics (IMMU) United States $10.247B 0.00
Bio-Techne Corp (TECH) United States $10.239B 70.86
Novavax (NVAX) United States $10.055B 0.00
Repligen (RGEN) United States $8.184B 129.90
Guardant Health (GH) United States $8.045B 0.00
Ascendis Pharma (ASND) Denmark $7.861B 0.00
Emergent Biosolutions (EBS) United States $7.116B 28.19
Exelixis (EXEL) United States $7.068B 24.78
ACADIA Pharmaceuticals (ACAD) United States $6.682B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.632B 205.46
SWEDISH ORP BIO (BIOVF) Sweden $6.351B 15.80
Vir Biotechnology (VIR) United States $5.972B 0.00
Acceleron Pharma (XLRN) United States $5.735B 0.00
Mirati Therapeutics (MRTX) United States $5.477B 0.00
MyoKardia (MYOK) United States $5.299B 0.00
Adaptive Biotechnologies (ADPT) United States $5.106B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.057B 0.00
Reata Pharmaceuticals (RETA) United States $5.032B 0.00
Zai Lab (ZLAB) China $4.718B 0.00
MorphoSys AG (MOR) Germany $4.570B 35.45
NeoGenomics (NEO) United States $4.453B 1344.00
China Biologic Products (CBPO) China $4.219B 23.45
Blueprint Medicines (BPMC) United States $4.185B 0.00
Global Blood Therapeutics (GBT) United States $4.138B 0.00
Halozyme Therapeutics (HALO) United States $3.941B 0.00
Amicus Therapeutics (FOLD) United States $3.891B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.849B 0.00
Bluebird Bio (BLUE) United States $3.454B 0.00
Inovio Pharmaceuticals (INO) United States $3.445B 0.00
Sorrento Therapeutics (SRNE) United States $3.336B 0.00
Arena Pharmaceuticals (ARNA) United States $3.243B 0.00
Alkermes (ALKS) Ireland $2.980B 62.47
Principia Biopharma (PRNB) United States $2.976B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.729B 0.00
Twist Bioscience (TWST) United States $2.723B 0.00
Insmed (INSM) United States $2.706B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Fate Therapeutics (FATE) United States $2.551B 0.00
Denali Therapeutics (DNLI) United States $2.455B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
Ligand Pharmaceuticals (LGND) United States $1.869B 63.29
UniQure (QURE) Netherlands $1.859B 0.00
Mesoblast (MESO) Australia $1.837B 0.00
Viela Bio (VIE) United States $1.807B 0.00
Editas Medicine (EDIT) United States $1.794B 0.00
I-Mab (IMAB) China $1.672B 0.00
Sangamo Therapeutics (SGMO) United States $1.620B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.610B 0.00
Eidos Therapeutics (EIDX) United States $1.598B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.583B 0.00
Adverum Biotechnologies (ADVM) United States $1.461B 0.00
Zymeworks (ZYME) Canada $1.424B 0.00
Zealand Pharma (ZEAL) Denmark $1.397B 0.00
Mersana Therapeutics (MRSN) United States $1.393B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.386B 0.00
Revance Therapeutics (RVNC) United States $1.376B 0.00
Intra-Cellular Therapies (ITCI) United States $1.376B 0.00
Epizyme (EPZM) United States $1.322B 0.00
Cytokineticsorporated (CYTK) United States $1.316B 0.00
NGM Biopharmaceuticals (NGM) United States $1.310B 0.00
Coherus BioSciences (CHRS) United States $1.288B 8.99
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
REGENXBIO (RGNX) United States $1.273B 0.00
Arvinas (ARVN) United States $1.203B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.180B 0.00
Alcobra (ARCT) United States $1.157B 0.00
Alector (ALEC) United States $1.152B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.135B 0.00
Compugen (CGEN) Israel $1.117B 0.00
Akcea Therapeutics (AKCA) United States $1.100B 0.00
Beam Therapeutics (BEAM) United States $1.096B 0.00
NantKwest (NK) United States $1.073B 0.00
VBI Vaccines (VBIV) United States $1.042B 0.00
Heska (HSKA) United States $1.011B 0.00
Intellia Therapeutics (NTLA) United States $1.010B 0.00
Retrophin (RTRX) United States $0.985B 0.00
Arcus Biosciences (RCUS) United States $0.979B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Athenex (ATNX) United States $0.931B 0.00
Myriad Genetics (MYGN) United States $0.929B 47.92
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.871B 0.00
Intrexon (PGEN) United States $0.842B 0.00
Dynavax Technologies (DVAX) United States $0.829B 0.00
Cara Therapeutics (CARA) United States $0.805B 0.00
Codexis (CDXS) United States $0.760B 0.00
Cellectis S.A (CLLS) France $0.755B 0.00
Morphic Holding (MORF) United States $0.746B 0.00
Pharming Group (PHGUF) Netherlands $0.745B 17.00
Castle Biosciences (CSTL) United States $0.726B 0.00
Vericel (VCEL) United States $0.718B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.705B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.676B 0.00
Frequency Therapeutics (FREQ) United States $0.669B 0.00
MiMedx (MDXG) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.601B 5.27
Biofrontera AG (BFRA) Germany $0.601B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.592B 0.00
Cue Biopharma (CUE) United States $0.583B 0.00
Agenus (AGEN) United States $0.573B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.537B 0.00
IBio (IBIO) United States $0.520B 0.00
Syros Pharmaceuticals (SYRS) United States $0.515B 0.00
Athersys (ATHX) United States $0.513B 0.00
Kala Pharmaceuticals (KALA) United States $0.500B 0.00
Clovis Oncology (CLVS) United States $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.491B 0.00
Prothena (PRTA) Ireland $0.490B 0.00
Innate Pharma S.A (IPHA) France $0.489B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
Anika Therapeutics (ANIK) United States $0.484B 21.17
Orchard Therapeutics (ORTX) United Kingdom $0.476B 0.00
UROGEN PHARMA (URGN) United States $0.470B 0.00
Cel-Sci (CVM) United States $0.462B 0.00
Protagonist Therapeutics (PTGX) United States $0.455B 0.00
AC Immune SA (ACIU) Switzerland $0.444B 0.00
BioDelivery Sciences (BDSI) United States $0.436B 31.11
Puma Biotechnology (PBYI) United States $0.429B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Prometic Life Sciences (LMNL) Canada $0.417B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.408B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Kamada (KMDA) Israel $0.398B 16.56
MannKind (MNKD) United States $0.396B 0.00
Scholar Rock Holding (SRRK) United States $0.395B 0.00
Merus (MRUS) Netherlands $0.391B 0.00
PDL BioPharma (PDLI) United States $0.383B 336.00
ANI Pharmaceuticals (ANIP) United States $0.382B 7.43
Albireo Pharma (ALBO) United States $0.362B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.356B 0.00
Precision BioSciences (DTIL) United States $0.352B 0.00
Geron (GERN) United States $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Seres Therapeutics (MCRB) United States $0.329B 0.00
WAVE Life Sciences (WVE) Singapore $0.322B 0.00
ChromaDex (CDXC) United States $0.316B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.310B 0.00
Menlo Therapeutics (MNLO) United States $0.309B 0.00
ADMA Biologics Inc (ADMA) United States $0.307B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.294B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Arbutus Biopharma (ABUS) United States $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.288B 0.00
Trevena (TRVN) United States $0.282B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
DBV Technologies S.A (DBVT) France $0.272B 0.00
Cellular Biomedicine (CBMG) United States $0.271B 0.00
Spero Therapeutics (SPRO) United States $0.270B 0.00
Pfenex (PFNX) United States $0.269B 0.00
NextCure (NXTC) United States $0.267B 0.00
Celldex Therapeutics (CLDX) United States $0.261B 0.00
Pluristem Therapeutics (PSTI) Israel $0.252B 0.00
Northwest Biotherapeutics (NWBO) United States $0.249B 0.00
Verastem (VSTM) United States $0.249B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Selecta Biosciences (SELB) United States $0.243B 0.00
Fortress Biotech (FBIO) United States $0.242B 0.00
Dyadic (DYAI) United States $0.237B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.236B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
HOOKIPA Pharma (HOOK) United States $0.229B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
Five Prime Therapeutics (FPRX) United States $0.220B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
Exicure (XCUR) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 9.60
Sutro Biopharma (STRO) United States $0.196B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.194B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
XOMA (XOMA) United States $0.184B 0.00
Cerecor (CERC) United States $0.183B 0.00
Aptinyx (APTX) United States $0.178B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.171B 0.00
Liquidia Technologies (LQDA) United States $0.170B 0.00
Bellus Health (BLU) Canada $0.168B 0.00
VTv Therapeutics (VTVT) United States $0.167B 0.00
Cidara Therapeutics (CDTX) United States $0.165B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Cyclerion Therapeutics (CYCN) United States $0.151B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.149B 0.00
Kindred Biosciences (KIN) United States $0.147B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Celyad SA (CYAD) Belgium $0.145B 0.00
Eton Pharmaceuticals (ETON) United States $0.144B 0.00
VolitionRX (VNRX) United States $0.142B 0.00
Applied Genetic Technologies (AGTC) United States $0.142B 0.00
Palatin Technologies (PTN) United States $0.133B 3.41
Lineage Cell Therapeutics (LCTX) United States $0.131B 0.00
Checkpoint Therapeutics (CKPT) United States $0.130B 0.00
Gritstone Oncology (GRTS) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.124B 0.00
PHASEBIO PHARMA (PHAS) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.122B 0.00
Oncobiologics (OTLK) United States $0.122B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.118B 0.00
Cardiff Oncology (CRDF) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Cocrystal Pharma (COCP) United States $0.115B 0.00
CorMedix Inc (CRMD) United States $0.113B 0.00
Vaccinex (VCNX) United States $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
AIT Therapeutics (XAIR) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.105B 0.00
AquaBounty Technologies (AQB) United States $0.102B 0.00
Organovo Holdings (ONVO) United States $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.086B 0.00
Unum Therapeutics (UMRX) United States $0.086B 0.00
Proteostasis Therapeutics (PTI) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Soligenix (SNGX) United States $0.067B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Bionano Genomics (BNGO) United States $0.063B 0.00
AnPac Bio-Medical Science (ANPC) China $0.063B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
IMMURON (IMRN) Australia $0.061B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Prima BioMed (IMMP) Australia $0.053B 0.00
Curis (CRIS) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.051B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prana Biotechnology (ATHE) Australia $0.042B 0.00
Spherix (AIKI) United States $0.041B 0.00
Celsion (CLSN) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.038B 0.00
OvaScience (MLND) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.031B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Novogen (KZIA) Australia $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
MYOS RENS Technology (MYOS) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Neuralstem (SNCA) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00